
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Sangamo Therapeutics France is the French subsidiary of Sangamo Therapeutics Inc. Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing, and gene regulation. For more information about Sangamo, visit www.sangamo.com. Sangamo Therapeutics France was formerly TxCell and was acquired by Sangamo Q4 2018
Genomic engineering,biotechnology,and research
Sangamo therapeutics france operates in the Biotechnology research industry.
Sangamo therapeutics france's revenue is 11m - 100m
Sangamo therapeutics france has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.